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Autoimmune TCR structure
 
crooked T cell receptor (TCR)–MHC interaction may
result in immune responses that are similarly skewed,
based on findings from Michael Hahn, Kai Wucherpfennig,
and colleagues (Dana-Farber Cancer Institute, Boston, MA). The
TCR in question is associated with multiple sclerosis, suggesting
that protective and autoimmune T cells recognize antigens differently.
A head-on approach has been seen in protective cases, in which
the TCR sits directly atop the foreign peptide/MHC complex on an
antigen-presenting cell. Now, the authors present the first crystal
structure of an autoimmunity-generating complex—a TCR that
binds to MHC presenting the myelin basic protein (MBP) peptide.
This structure, derived from a TCR that was isolated from a
multiple sclerosis patient, reveals a tilted complex in which the
TCR contacted mostly the NH
 
2
 
-terminal portion of the MBP
peptide. The hypervariable (rearranged) TCR loops created a much
larger fraction of the contact surface with the MHC and peptide
than in conventional arrangements. “It’s the sequence diversity of
TCRs that allows these unusual topologies,” says Wucherpfennig.
The CD4 coreceptor, which is required for T cell function, was
A 
An autoimmune TCR (left; red and yellow) sits off-center on its 
MHC (blue) and peptide (green) compared with a more conventional 
arrangement (right).
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thus unusually positioned. If this odd geometry limits T cell activation in the thymus, the cell might evade
negative selection (the removal of autoreactive T cells) and escape to the periphery. Escapees remain harmless
unless they are activated, possibly by microbial peptides with some structural similarity to MBP. This kind of
activation might be more likely since the TCR recognizes a smaller-than-normal section of the peptide. 
 
Reference: Hahn, M., et al. 2005. 
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Quick stop for lymphocytes
 
ymphocytes reach out a retractable
hook to stop on a dime when
necessary, based on findings from
Revital Shamri, Ronen Alon (Weizmann
Institute of Science, Rehovot Israel), and
colleagues.
Lymphocytes and other white blood
cells roll along vessel walls scanning for
immobilized chemokine signals that tell
them where to stop on the endothelium.
They only stop once their integrins, which
are otherwise kept bent and inactive, are
properly activated. As arrest requires
dramatic adhesion changes, most scientists
assumed that rolling allowed signals to
accumulate and globally activate integrins,
thus decelerating and eventually stopping
the rolling cell. In some settings, such as
neutrophils rolling on E-selectin, deceler-
ation lasts several minutes. But the new
findings show a much more abrupt stop
of lymphocytes on the endothelium.
Rolling was not even necessary for
neutrophils to stop. Endothelium-bound
chemokines needed less than 0.3 s in
L
 
Research Roundup
 
contact with the neutrophil integrin LFA-1 to
trigger its extension. Extended LFA-1 can
more easily reach its endothelial ligand
(such as ICAM-1) but does not bind it
tightly. To latch on, the group shows,
the integrin must encounter its ligand less
than 0.5 s after seeing the initial chemo-
kine signal.
“The integrin ligand should be very
close to the chemokine,” says Alon. “If cells
Rolling lymphocytes do not gradually decelerate 
before stopping.
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see sporadic chemokine spatially misorgan-
ized [with respect to the integrin’s ligand],
it results in an abortive activation signal.”
The hook is quickly retracted, and the cell
rolls on. Integration of chemokine signaling
is not necessary, so cells stop precisely
where a signal lies, rather than rolling and
collecting signals over a long path.
Recent structural data fit well with
the findings. Integrin structures reveal
“an intermediate state when integrin is
extended, primed, but not fully committed,”
says Alon. Intracellular signals, as might
be generated by rapidly activated
chemokine receptors on the lymphocytes,
get integrins to that state by what is
known as inside-out signaling. “For
proper acquistion of high affinity,” says
Alon, “the ligand must do the next half.”
Since the ligand must act quickly, Alon
suggests that “the integrin and chemokine
machineries are preformed on the lym-
phocyte surface.” 
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